Bone Remodeling and Non-surgical Periodontal Therapy

December 12, 2022 updated by: Firas Bashir Hashim Al-Taweel, University of Baghdad

Evaluation of Bone Remodeling Markers Following Non-surgical Periodontal Therapy in Periodontitis Patients (Prospective Clinical Trial)

Previous studied have investigated the pathophysiological role and expression of Cathepsin K (Ctsk) , receptor activator of the NF-κB ligand (RANKL) and periostin in active periodontitis and peri-implantitis lesions. However, the potential influence of non-surgical periodontal therapy including scaling and root planning on the bone remodeling markers level over different trial times have not well determined. Thus, the current research is conducted to address this influence. Thus, the research question will be: In patients with periodontitis, does the level of bone remodeling markers altered after successful NSPT during different healing time periods?

Study Overview

Status

Enrolling by invitation

Intervention / Treatment

Study Type

Interventional

Enrollment (Anticipated)

25

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Baghdad, Iraq, +964
        • College of Dentistry, University of Baghdad

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years to 61 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Both males and females.
  2. Unstable periodontitis.
  3. No previous periodontal treatment is conducted during the past 6 months.
  4. Good general health without history of any systemic diseases.
  5. Present with at least 20 teeth.
  6. Non-smokers.

Exclusion Criteria:

  1. Subjects have any intraoral plaque retentive factors such as those wearing partial denture, crown and bridges, and orthodontic appliances.
  2. Subjects receiving antibiotic therapy during the previous 3 months.
  3. Pregnant or lactating women.
  4. Smokers.
  5. Not willing to participate or continue to conduct the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Periodontitis treated with Root surface debridement
Immediately after inclusion in the study, the patient's examination with saliva sampling will be conducted as follows: At a base line visit (Zero time visit), subjects will be examined for clinical periodontal parameters, their saliva samples will be collected, and then receiving full scaling using ultrasonic device, and oral hygiene instructions and motivation. After one week, the same clinical parameters, saliva sampling will be taken, and received full root surface debridement (RSD) using curette hand instruments (Gracey, USA) (First visit). One month and three months after first visit, the same clinical measurements, saliva will characterize as second and third visits, respectively.
subjects will be examined for clinical periodontal parameters, their saliva samples will be collected, and then receiving full scaling using ultrasonic device, and oral hygiene instructions and motivation. After one week, the same clinical parameters, saliva sampling will be taken, and received full root surface debridement (RSD) using curette hand instruments (Gracey, USA) (First visit). One month and three months after first visit, the same clinical measurements, saliva will characterize as second and third visits, respectively.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Bone remodeling markers including salivary RANKL
Time Frame: At a base line visit (Zero time visit), After one week (first visit), and One month and three months after first visit
To investigate the alterations in the level of salivary RANKL pg/ml following Non-surgical periodontal therapy in unstable periodontitis patients during different healing time periods.
At a base line visit (Zero time visit), After one week (first visit), and One month and three months after first visit
Bone remodeling markers including salivary Cathepsin k
Time Frame: At a base line visit (Zero time visit), After one week (first visit), and One month and three months after first visit
To investigate the alterations in the level of salivary Cathepsin k pg/ml following Non-surgical periodontal therapy in unstable periodontitis patients during different healing time periods.
At a base line visit (Zero time visit), After one week (first visit), and One month and three months after first visit
Bone remodeling markers including salivary periostin
Time Frame: At a base line visit (Zero time visit), After one week (first visit), and One month and three months after first visit
To investigate the alterations in the level of salivary periostin pg/ml following Non-surgical periodontal therapy in unstable periodontitis patients during different healing time periods.
At a base line visit (Zero time visit), After one week (first visit), and One month and three months after first visit

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Clinical periodontal parameters including Bleeding on probing
Time Frame: At a base line visit (Zero time visit), After one week (first visit), and One month and three months after first visit
To measure Clinical periodontal parameters including Bleeding on probing following Non-surgical periodontal therapy in unstable periodontitis patients during different healing time periods.
At a base line visit (Zero time visit), After one week (first visit), and One month and three months after first visit
Clinical periodontal parameters including probing pocket depth
Time Frame: At a base line visit (Zero time visit), After one week (first visit), and One month and three months after first visit
To measure Clinical periodontal parameters including probing pocket depth following Non-surgical periodontal therapy in unstable periodontitis patients during different healing time periods.
At a base line visit (Zero time visit), After one week (first visit), and One month and three months after first visit
Clinical periodontal parameters including clinical attachment loss
Time Frame: At a base line visit (Zero time visit), After one week (first visit), and One month and three months after first visit
To measure Clinical periodontal parameters including clinical attachment loss following Non-surgical periodontal therapy in unstable periodontitis patients during different healing time periods.
At a base line visit (Zero time visit), After one week (first visit), and One month and three months after first visit

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Firas B. Al-Taweel, PhD, Periodontics department, College of Dentistry/University of Baghdad

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2022

Primary Completion (Anticipated)

January 1, 2023

Study Completion (Anticipated)

March 1, 2023

Study Registration Dates

First Submitted

November 23, 2022

First Submitted That Met QC Criteria

November 23, 2022

First Posted (Actual)

December 5, 2022

Study Record Updates

Last Update Posted (Estimate)

December 15, 2022

Last Update Submitted That Met QC Criteria

December 12, 2022

Last Verified

December 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • 665622

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Periodontal Diseases

Clinical Trials on Root surface debridement

Subscribe